240 related articles for article (PubMed ID: 2109073)
1. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
Roth SH
J Rheumatol Suppl; 1990 Feb; 20():20-4. PubMed ID: 2109073
[TBL] [Abstract][Full Text] [Related]
2. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.
Graham DY; Agrawal NM; Roth SH
Lancet; 1988 Dec; 2(8623):1277-80. PubMed ID: 2904006
[TBL] [Abstract][Full Text] [Related]
3. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
Delmas PD; Lambert R; Capron MH
Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
[TBL] [Abstract][Full Text] [Related]
4. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
5. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
8. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
Agrawal NM; Aziz K
J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac/misoprostol: the European clinical experience.
McKenna F
J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.
Agrawal NM; Roth S; Graham DY; White RH; Germain B; Brown JA; Stromatt SC
Ann Intern Med; 1991 Aug; 115(3):195-200. PubMed ID: 1905501
[TBL] [Abstract][Full Text] [Related]
12. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of prostanoids in the treatment of gastric ulcer.
Rachmilewitz D
Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
Bach GL; Stock KP; Hüdepohl M
Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal antiinflammatory drug therapy in elderly patients. A multicenter double-blind, placebo-controlled trial.
Piette F; Teillet L; Naudin R; Boichut D; Capron MH
Rev Rhum Engl Ed; 1997 Apr; 64(4):259-66. PubMed ID: 9178399
[TBL] [Abstract][Full Text] [Related]
18. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050
[TBL] [Abstract][Full Text] [Related]
19. P & T committee review of misoprostol: prevention of NSAID side effects is key--roundtable discussion.
Weintraub M; Fries J; Graham D; Knodel LC; Silverstein F
Hosp Formul; 1989 Feb; 24 Suppl A():7-12. PubMed ID: 10291816
[TBL] [Abstract][Full Text] [Related]
20. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs.
Hillman AL; Bloom BS
Arch Intern Med; 1989 Sep; 149(9):2061-5. PubMed ID: 2505706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
